Exploring Antiviral Immune Responses and Therapeutic Strategies Against Human Coronaviruses

1,777
Total downloads
9,813
Total views and downloads

Participate in this topic

Articles

ORIGINAL RESEARCH

Accepted on 10 Mar 2025

Effectiveness of early intervention and combination treatment with monoclonal antibodies and antivirals in oncohematological patients with SARS-CoV-2: a retrospective experience

Silvia Di Bari
Francesco Izzo
Livia Bresciani
Giulia Mancarella
Silvia Garattini
Andrea Gasperin
Daniela Di Trento
Alessandra Grimaldi
Alberico Parente
10 more
Miriam Lichtner

doi 10.3389/fimmu.2025.1524525

ORIGINAL RESEARCH

Accepted on 06 Mar 2025

Anti-S2 antibodies responsible for the SARS-CoV-2 infection-induced serological cross-reactivity against MERS-CoV and MERS-related coronaviruses

Minxiang Xie
Qiao Wang
Lei Sun
Siyuan Sun
Jiaying He
Luotian Liu
Yuzhen Zhu
Yuru Han
Song Xue
10 more
Lu Lu

doi 10.3389/fimmu.2025.1541269

ORIGINAL RESEARCH

Published on 06 Jan 2025

Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity

Stephane Isnard
Tsoarello Mabanga
Léna Royston
Carolina A. Berini
Simeng Bu
Orthy Aiyana
Hansen Feng
Bertrand Lebouché
Cecilia T. Costiniuk
4 more
the Biobanque Québécoise de la COVID-19 (BQC-19)

doi 10.3389/fimmu.2024.1505752

795 views

ORIGINAL RESEARCH

Published on 27 Nov 2024

Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement

Elena Criscuolo
Benedetta Giuliani
Matteo Castelli
Mattia Cavallaro
Sofia Sisti
Roberto Burioni
Davide Ferrari
Nicasio Mancini
Massimo Locatelli
Nicola Clementi

doi 10.3389/fimmu.2024.1501200

671 views

ORIGINAL RESEARCH

Published on 27 Nov 2024

Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested case-control study

Andrea Alemany
Núria Balanza
Pere Millat-Martinez
Dan Ouchi
Marc Corbacho-Monné
Cristian Morales-Indiano
Gema Fernández Rivas
Ignacio Blanco
Oriol Mitjà
5 more
COnV-ert BMK STUDY GROUP

doi 10.3389/fimmu.2024.1501872

4,118 views

REVIEW

Published on 26 Nov 2024

Exosomes and SARS-CoV-2 infection

Liuying Li
Zixuan Yang
Jia Li

doi 10.3389/fimmu.2024.1467109

1,013 views

ORIGINAL RESEARCH

Published on 24 Oct 2024

IgG1 versus IgG3: influence of antibody-specificity and allotypic variance on virus neutralization efficacy

Somanath Kallolimath
Lin Sun
Roman Palt
Esther Föderl-Höbenreich
Antonia Hermle
Leonie Voss
Marina Kleim
Falk Nimmerjahn
Johannes S. Gach
5 more
Herta Steinkellner

doi 10.3389/fimmu.2024.1490515

873 views

Share on

Frontiers in Immunology

Viral Immunology

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

9,813Topic views
7,242Article views
1,777Article downloads

View impact

Articles

Effectiveness of early intervention and combination treatment with monoclonal antibodies and antivirals in oncohematological patients with SARS-CoV-2: a retrospective experience

Anti-S2 antibodies responsible for the SARS-CoV-2 infection-induced serological cross-reactivity against MERS-CoV and MERS-related coronaviruses

Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity

Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement

Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested case-control study

Exosomes and SARS-CoV-2 infection

IgG1 versus IgG3: influence of antibody-specificity and allotypic variance on virus neutralization efficacy

Frontiers in Immunology

Viral Immunology